Cardiff MedTech Diurnal is set to be acquired in a deal which values the company at £48.3 million. San Diego company Neurocrine has agreed the deal for Diurnal, subject to approval from London-listed Diurnal’s shareholders. Under the terms of the acquisition, Diurnal shareholders would receive 27.5 pence in cash for each share, representing a premium … Continue reading Cardiff MedTech set for £48m takeover